NDC 72934-6120

HYDROQUINONE 6% / TRETINOIN 0.05% / TRIAMCINOLONE 0.025%

Hydroquinone 6% / Tretinoin 0.05% / Triamcinolone 0.025%

HYDROQUINONE 6% / TRETINOIN 0.05% / TRIAMCINOLONE 0.025% is a Topical Emulsion in the Human Prescription Drug category. It is labeled and distributed by Sincerus Florida, Llc. The primary component is Hydroquinone; Tretinoin; Triamcinolone Acetonide.

Product ID72934-6120_8953d7fa-bfe3-9595-e053-2995a90abfbc
NDC72934-6120
Product TypeHuman Prescription Drug
Proprietary NameHYDROQUINONE 6% / TRETINOIN 0.05% / TRIAMCINOLONE 0.025%
Generic NameHydroquinone 6% / Tretinoin 0.05% / Triamcinolone 0.025%
Dosage FormEmulsion
Route of AdministrationTOPICAL
Marketing Start Date2019-05-20
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameSincerus Florida, LLC
Substance NameHYDROQUINONE; TRETINOIN; TRIAMCINOLONE ACETONIDE
Active Ingredient Strength6 g/100g; g/100g; g/100g
Pharm ClassesMelanin Synthesis Inhibitor [EPC],Melanin Synthesis Inhibitors [MoA],Depigmenting Activity [PE],Retinoid [EPC],Retinoids [CS],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 72934-6120-2

30 g in 1 BOTTLE, PUMP (72934-6120-2)
Marketing Start Date2019-05-20
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 72934-6120-2 [72934612002]

HYDROQUINONE 6% / TRETINOIN 0.05% / TRIAMCINOLONE 0.025% EMULSION
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-05-20

Drug Details

Active Ingredients

IngredientStrength
HYDROQUINONE6 g/100g

OpenFDA Data

SPL SET ID:8953d7fa-bfe2-9595-e053-2995a90abfbc
Manufacturer
UNII

Pharmacological Class

  • Melanin Synthesis Inhibitor [EPC]
  • Melanin Synthesis Inhibitors [MoA]
  • Depigmenting Activity [PE]
  • Retinoid [EPC]
  • Retinoids [CS]
  • Corticosteroid [EPC]
  • Corticosteroid Hormone Receptor Agonists [MoA]
  • Melanin Synthesis Inhibitor [EPC]
  • Melanin Synthesis Inhibitors [MoA]
  • Depigmenting Activity [PE]
  • Retinoid [EPC]
  • Retinoids [CS]
  • Corticosteroid [EPC]
  • Corticosteroid Hormone Receptor Agonists [MoA]

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.